[HTML][HTML] Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

S Nanni, V Benvenuti, A Grasselli… - The Journal of …, 2009 - Am Soc Clin Investig
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

[PDF][PDF] Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

A Aiello, S Mattiussi, C Colussi, V Lirangi, B Illi… - tara.tcd.ie
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

[PDF][PDF] Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

A Aiello, S Mattiussi, C Colussi, V Lirangi, B Illi… - Am Soc Clin Investig
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

S Nanni, V Benvenuti, A Grasselli… - The Journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

S Nanni, V Benvenuti, A Grasselli… - Journal of Clinical …, 2009 - pure.johnshopkins.edu
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

[PDF][PDF] Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

A Aiello, S Mattiussi, C Colussi, V Lirangi, B Illi… - academia.edu
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

S Nanni, V Benvenuti, A Grasselli, C Priolo, A Aiello… - 2009 - Am Soc Clin Investig
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

Endothelial NOS, estrogen receptor [beta], and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

S Nanni, V Benvenuti, A Grasselli… - Journal of Clinical …, 2009 - search.proquest.com
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

[PDF][PDF] Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

A Aiello, S Mattiussi, C Colussi, V Lirangi, B Illi… - researchgate.net
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …

Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.

S Nanni, V Benvenuti, A Grasselli, C Priolo… - Journal of Clinical …, 2009 - go.gale.com
The identification of biomarkers that distinguish between aggressive and indolent forms of
prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured …